Evidence method
Level · gp.fundamentals.debt_to_revenue
1119.92% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
VRCA · Mar 31, 2024
Verrica Pharmaceuticals Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-058208General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-521.35% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
65.32% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
81.70% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-486.12% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
129.33% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
54.16% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/5 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20252/7 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 836.73%
- Current
- 1119.92%
- Delta
- 283.19%
- Previous
- 7.06%
- Current
- 0.00%
- Delta
- -7.06%
- Previous
- -752.87%
- Current
- -521.35%
- Delta
- 231.51%
- Previous
- 19.95%
- Current
- 65.32%
- Delta
- 45.37%
- Previous
- 90.24%
- Current
- 81.70%
- Delta
- -8.54%
- Previous
- -1283.35%
- Current
- -486.12%
- Delta
- 797.23%
- Previous
- 396.08%
- Current
- 129.33%
- Delta
- -266.75%
- Previous
- 280.56%
- Current
- 54.16%
- Delta
- -226.41%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · VRCA Fundamental State →Has State · Verrica Pharmaceuticals Inc. →Transitioned To · VRCA Fundamental State →Transitioned To · VRCA BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · VRCA CAPEX_INTENSITY_DECREASED →Transitioned To · VRCA CASH_GENERATION_INCREASED →Transitioned To · VRCA INVENTORY_PRESSURE_INCREASED →Transitioned To · VRCA MARGIN_DECREASED →Transitioned To · VRCA PROFITABILITY_INCREASED →Transitioned To · VRCA R_AND_D_INTENSITY_DECREASED →Transitioned To · VRCA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.